Emerging Economies Challenge Global Intellectual Property Norms to Expand Access to Medicines

In 1997, South Africa’s attempt to amend its laws to allow affordable generic medicines for HIV/AIDS treatment met fierce resistance from the global pharmaceutical industry, delaying implementation and causing significant human costs. Although South Africa ultimately prevailed legally, the experience deterred further challenges to the prevailing international intellectual property (IP) regime — until now. The South African cabinet is preparing to finalize an IP policy aimed at substantially expanding access to medicines, a move expected to provoke pressure from wealthy countries but one that aligns with growing global calls for reform.

Over the past two decades, developing countries have increasingly pushed back against a one-size-fits-all IP model imposed largely by wealthy nations through World Trade Organization (WTO) rules and trade agreements. These stringent IP standards often prioritize maximizing profits for large pharmaceutical corporations over fostering innovation or addressing public health needs.

Countries with significant industrial bases, including South Africa, India, and Brazil, are leading this counterattack by focusing on the most visible inequities: access to essential medicines. India’s 2005 patent law amendment introduced mechanisms to balance patent protections with public health imperatives, a law that has withstood domestic and international scrutiny and complies with WTO standards. Brazil’s early government initiatives to provide HIV/AIDS treatment successfully lowered drug prices through negotiations.

Scholars argue that the current IP regime is neither equitable nor efficient. A comprehensive review of intellectual property’s role in development reveals that existing laws and institutions protecting knowledge in advanced economies are increasingly inadequate for governing global economic activity and fail to meet the needs of developing countries. These laws often obstruct access to basic human necessities such as healthcare.

The fundamental challenge is that knowledge is a global public good: its use by one person does not diminish availability to others, and its expansion benefits global wellbeing. Historically, concerns about underinvestment in research led to the establishment of private monopolies via patents to incentivize innovation. However, this approach has proven problematic, even in advanced economies.

The proliferation of overlapping patents, or “patent thickets,” has sometimes stifled innovation, with resources diverted to legal battles rather than research. Moreover, research efforts often focus on extending patent monopolies rather than creating genuinely new products.

A landmark 2013 U.S. Supreme Court ruling that naturally occurring genes cannot be patented has provided empirical evidence that loosening patent restrictions can accelerate innovation. Following this decision, improved and more affordable diagnostic tests for genes linked to breast cancer have emerged.

Alternative models to incentivize research include centralized direct funding through institutions like the U.S. National Institutes of Health, decentralized funding via tax credits, and prize systems rewarding successful innovations. Unlike patents, which can impede knowledge dissemination and distort markets, these alternatives can foster a more open and collaborative innovation environment, exemplified by open-source software.

Developing countries should adopt a combination of these strategies to promote learning and innovation. Economic growth and human development depend heavily on technological change and knowledge diffusion. Bridging the knowledge gap between developed and developing countries is critical to maximizing global social welfare.

Despite strong theoretical support for a more open IP system, the global trend over the past 30 years has been toward more restrictive IP protections, often widening the gap between social and private returns on innovation. Powerful lobbies in advanced economies have influenced this trajectory, resisting recognition of intellectual property rights related to traditional knowledge and biodiversity.

Historically, even early industrializers delayed adopting strong IP protections to accelerate industrial growth. The current regime, shaped over 25 years ago under political pressure from select sectors in wealthy countries, no longer fits the realities of the 21st-century global economy.

Today, emerging economies like South Africa, India, and Brazil hold greater economic weight, and the “weightless economy” of ideas and information constitutes an increasing share of global output. The governance of global knowledge must evolve accordingly. Continuing to prioritize profits for a few over global development and welfare is unsustainable and misaligned with contemporary economic and social imperatives.